Structure

Physi-Chem Properties

Molecular Weight:  616.11
Volume:  559.068
LogP:  1.102
LogD:  0.269
LogS:  -4.765
# Rotatable Bonds:  7
TPSA:  277.27
# H-Bond Aceptor:  16
# H-Bond Donor:  10
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.075
Synthetic Accessibility Score:  4.944
Fsp3:  0.214
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.342
MDCK Permeability:  2.43872946157353e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.205
20% Bioavailability (F20%):  0.279
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.006
Plasma Protein Binding (PPB):  90.49224090576172%
Volume Distribution (VD):  0.641
Pgp-substrate:  17.807931900024414%

ADMET: Metabolism

CYP1A2-inhibitor:  0.317
CYP1A2-substrate:  0.016
CYP2C19-inhibitor:  0.033
CYP2C19-substrate:  0.035
CYP2C9-inhibitor:  0.276
CYP2C9-substrate:  0.062
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.092
CYP3A4-inhibitor:  0.02
CYP3A4-substrate:  0.003

ADMET: Excretion

Clearance (CL):  1.784
Half-life (T1/2):  0.847

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.204
Drug-inuced Liver Injury (DILI):  0.993
AMES Toxicity:  0.595
Rat Oral Acute Toxicity:  0.036
Maximum Recommended Daily Dose:  0.013
Skin Sensitization:  0.832
Carcinogencity:  0.148
Eye Corrosion:  0.003
Eye Irritation:  0.221
Respiratory Toxicity:  0.032

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC171706

Natural Product ID:  NPC171706
Common Name*:   Balanophotannin D
IUPAC Name:   [(2R,3S,4S,5R,6S)-6-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (1S)-7,8,9-trihydroxy-3,5-dioxo-1,2-dihydrocyclopenta[c]isochromene-1-carboxylate
Synonyms:   balanophotannin D
Standard InCHIKey:  URJGURKNABRVCH-ATYMIDRYSA-N
Standard InCHI:  InChI=1S/C28H24O16/c29-12-3-1-9(5-13(12)30)2-4-17(33)43-28-24(38)23(37)21(35)16(42-28)8-41-26(39)11-7-15(32)25-19(11)18-10(27(40)44-25)6-14(31)20(34)22(18)36/h1-6,11,16,21,23-24,28-31,34-38H,7-8H2/b4-2+/t11-,16+,21+,23-,24+,28-/m0/s1
SMILES:  O=C(O[C@@H]1O[C@H](COC(=O)[C@H]2CC(=O)c3c2c2c(O)c(O)c(cc2c(=O)o3)O)[C@H]([C@@H]([C@H]1O)O)O)/C=C/c1ccc(c(c1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL506571
PubChem CID:   24862008
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0003002] Hydroxycinnamic acid esters
            • [CHEMONTID:0003003] Hydroxycinnamic acid glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15233 Balanophora japonica Species Balanophoraceae Eukaryota n.a. n.a. n.a. PMID[18302336]
NPO15233 Balanophora japonica Species Balanophoraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15233 Balanophora japonica Species Balanophoraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15233 Balanophora japonica Species Balanophoraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 = 17410.0 nM PMID[525215]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC171706 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9699 High Similarity NPC198902
0.9091 High Similarity NPC14030
0.9091 High Similarity NPC291957
0.907 High Similarity NPC170203
0.9036 High Similarity NPC470898
0.9006 High Similarity NPC473713
0.8971 High Similarity NPC475360
0.8896 High Similarity NPC125487
0.8896 High Similarity NPC281703
0.8882 High Similarity NPC155763
0.8882 High Similarity NPC20505
0.8882 High Similarity NPC235260
0.8876 High Similarity NPC470271
0.8876 High Similarity NPC311389
0.8848 High Similarity NPC135222
0.8848 High Similarity NPC474010
0.8844 High Similarity NPC253521
0.8844 High Similarity NPC37668
0.8844 High Similarity NPC113836
0.8837 High Similarity NPC253685
0.8834 High Similarity NPC161159
0.883 High Similarity NPC175107
0.883 High Similarity NPC190003
0.8827 High Similarity NPC140151
0.8824 High Similarity NPC138927
0.8817 High Similarity NPC175793
0.8786 High Similarity NPC61904
0.8786 High Similarity NPC144097
0.8786 High Similarity NPC296018
0.8786 High Similarity NPC154741
0.8779 High Similarity NPC4390
0.8773 High Similarity NPC92747
0.8773 High Similarity NPC265862
0.8772 High Similarity NPC116864
0.8772 High Similarity NPC244776
0.8772 High Similarity NPC470272
0.8765 High Similarity NPC43918
0.8765 High Similarity NPC261411
0.8765 High Similarity NPC9099
0.8765 High Similarity NPC190204
0.8736 High Similarity NPC267680
0.8736 High Similarity NPC217387
0.8736 High Similarity NPC293626
0.8736 High Similarity NPC35167
0.8736 High Similarity NPC476773
0.8736 High Similarity NPC196127
0.8736 High Similarity NPC258044
0.8735 High Similarity NPC187205
0.8735 High Similarity NPC49173
0.8728 High Similarity NPC34267
0.8728 High Similarity NPC223426
0.8728 High Similarity NPC81042
0.8728 High Similarity NPC115760
0.8728 High Similarity NPC135277
0.8728 High Similarity NPC214621
0.8728 High Similarity NPC210094
0.8728 High Similarity NPC101191
0.8728 High Similarity NPC43211
0.8728 High Similarity NPC49344
0.8728 High Similarity NPC237435
0.8721 High Similarity NPC153755
0.872 High Similarity NPC61152
0.872 High Similarity NPC16024
0.872 High Similarity NPC3746
0.872 High Similarity NPC205037
0.872 High Similarity NPC44260
0.8708 High Similarity NPC7839
0.8708 High Similarity NPC173872
0.8708 High Similarity NPC142291
0.8708 High Similarity NPC119094
0.8706 High Similarity NPC145038
0.8706 High Similarity NPC281131
0.8706 High Similarity NPC56077
0.8706 High Similarity NPC253662
0.8706 High Similarity NPC274618
0.8706 High Similarity NPC118284
0.8706 High Similarity NPC276222
0.8706 High Similarity NPC88789
0.8706 High Similarity NPC308404
0.8706 High Similarity NPC179950
0.8704 High Similarity NPC92117
0.8693 High Similarity NPC135831
0.8693 High Similarity NPC297503
0.8693 High Similarity NPC97119
0.8678 High Similarity NPC211532
0.8678 High Similarity NPC471669
0.8678 High Similarity NPC297574
0.8678 High Similarity NPC472385
0.8678 High Similarity NPC233994
0.8678 High Similarity NPC198324
0.8678 High Similarity NPC472723
0.8678 High Similarity NPC89127
0.8678 High Similarity NPC268533
0.8663 High Similarity NPC136042
0.8663 High Similarity NPC29958
0.8663 High Similarity NPC47521
0.8663 High Similarity NPC72249
0.8663 High Similarity NPC67326
0.8663 High Similarity NPC156869
0.8663 High Similarity NPC259896
0.8663 High Similarity NPC255157
0.8663 High Similarity NPC254855
0.8663 High Similarity NPC206123
0.8659 High Similarity NPC201814
0.8655 High Similarity NPC223424
0.8655 High Similarity NPC84362
0.8655 High Similarity NPC317489
0.8655 High Similarity NPC149244
0.8655 High Similarity NPC173637
0.8655 High Similarity NPC48640
0.8655 High Similarity NPC31034
0.8655 High Similarity NPC92565
0.8655 High Similarity NPC127546
0.8655 High Similarity NPC160156
0.8655 High Similarity NPC52550
0.8647 High Similarity NPC19388
0.8647 High Similarity NPC240431
0.8647 High Similarity NPC55786
0.8647 High Similarity NPC277205
0.8644 High Similarity NPC231254
0.8642 High Similarity NPC120621
0.8642 High Similarity NPC248257
0.8639 High Similarity NPC145847
0.8636 High Similarity NPC208797
0.8636 High Similarity NPC53680
0.8631 High Similarity NPC24627
0.8629 High Similarity NPC173837
0.8629 High Similarity NPC469418
0.8629 High Similarity NPC139571
0.8629 High Similarity NPC217520
0.8623 High Similarity NPC472860
0.8621 High Similarity NPC264735
0.8621 High Similarity NPC477848
0.8614 High Similarity NPC203757
0.8613 High Similarity NPC33054
0.8613 High Similarity NPC203259
0.8613 High Similarity NPC471748
0.8613 High Similarity NPC60735
0.8613 High Similarity NPC176740
0.8613 High Similarity NPC26230
0.8613 High Similarity NPC245452
0.8613 High Similarity NPC471725
0.8613 High Similarity NPC155877
0.8613 High Similarity NPC134532
0.8605 High Similarity NPC120099
0.8605 High Similarity NPC270578
0.8605 High Similarity NPC203050
0.8605 High Similarity NPC225434
0.8605 High Similarity NPC328321
0.8605 High Similarity NPC52382
0.8605 High Similarity NPC219904
0.8605 High Similarity NPC223747
0.8596 High Similarity NPC255615
0.8596 High Similarity NPC21100
0.8596 High Similarity NPC197285
0.8596 High Similarity NPC113968
0.8596 High Similarity NPC328940
0.8596 High Similarity NPC277174
0.8596 High Similarity NPC135599
0.8596 High Similarity NPC73855
0.8596 High Similarity NPC67037
0.8588 High Similarity NPC36138
0.8588 High Similarity NPC470718
0.8588 High Similarity NPC156785
0.8588 High Similarity NPC470449
0.8588 High Similarity NPC470446
0.8588 High Similarity NPC241781
0.8588 High Similarity NPC470445
0.8588 High Similarity NPC107987
0.8588 High Similarity NPC109990
0.8588 High Similarity NPC168822
0.8588 High Similarity NPC470447
0.8588 High Similarity NPC162394
0.858 High Similarity NPC80956
0.858 High Similarity NPC195114
0.8571 High Similarity NPC472380
0.8571 High Similarity NPC470949
0.8571 High Similarity NPC8573
0.8571 High Similarity NPC472384
0.8571 High Similarity NPC472382
0.8571 High Similarity NPC65563
0.8571 High Similarity NPC473862
0.8563 High Similarity NPC169977
0.8563 High Similarity NPC42773
0.8563 High Similarity NPC473550
0.8563 High Similarity NPC46640
0.8563 High Similarity NPC45522
0.8563 High Similarity NPC21666
0.8563 High Similarity NPC24043
0.8563 High Similarity NPC219600
0.8563 High Similarity NPC34436
0.8563 High Similarity NPC166674
0.8563 High Similarity NPC101026
0.8563 High Similarity NPC263119
0.8555 High Similarity NPC181778
0.8555 High Similarity NPC95866
0.8555 High Similarity NPC285197
0.8555 High Similarity NPC149011
0.8555 High Similarity NPC245014
0.8555 High Similarity NPC84265

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC171706 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8728 High Similarity NPD4338 Clinical (unspecified phase)
0.8613 High Similarity NPD6797 Phase 2
0.8563 High Similarity NPD7251 Discontinued
0.8547 High Similarity NPD3818 Discontinued
0.8409 Intermediate Similarity NPD7808 Phase 3
0.8343 Intermediate Similarity NPD7472 Approved
0.8343 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8295 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8294 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD7054 Approved
0.8239 Intermediate Similarity NPD7074 Phase 3
0.8167 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8146 Intermediate Similarity NPD7685 Pre-registration
0.8142 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD7228 Approved
0.8079 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8035 Intermediate Similarity NPD6234 Discontinued
0.8012 Intermediate Similarity NPD1465 Phase 2
0.8011 Intermediate Similarity NPD6166 Phase 2
0.8011 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6190 Approved
0.7965 Intermediate Similarity NPD3817 Phase 2
0.7953 Intermediate Similarity NPD37 Approved
0.7943 Intermediate Similarity NPD7199 Phase 2
0.7941 Intermediate Similarity NPD4380 Phase 2
0.7919 Intermediate Similarity NPD4967 Phase 2
0.7919 Intermediate Similarity NPD3882 Suspended
0.7919 Intermediate Similarity NPD4966 Approved
0.7919 Intermediate Similarity NPD4965 Approved
0.7877 Intermediate Similarity NPD5844 Phase 1
0.7874 Intermediate Similarity NPD7075 Discontinued
0.7865 Intermediate Similarity NPD7473 Discontinued
0.7861 Intermediate Similarity NPD5402 Approved
0.7849 Intermediate Similarity NPD1934 Approved
0.7821 Intermediate Similarity NPD3751 Discontinued
0.7803 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD6232 Discontinued
0.7765 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD8313 Approved
0.776 Intermediate Similarity NPD8312 Approved
0.7758 Intermediate Similarity NPD7266 Discontinued
0.7747 Intermediate Similarity NPD7240 Approved
0.7747 Intermediate Similarity NPD6559 Discontinued
0.7746 Intermediate Similarity NPD6801 Discontinued
0.772 Intermediate Similarity NPD7435 Discontinued
0.7719 Intermediate Similarity NPD1653 Approved
0.7706 Intermediate Similarity NPD1512 Approved
0.7701 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7701 Intermediate Similarity NPD2801 Approved
0.768 Intermediate Similarity NPD8320 Phase 1
0.768 Intermediate Similarity NPD8319 Approved
0.7669 Intermediate Similarity NPD230 Phase 1
0.7661 Intermediate Similarity NPD5403 Approved
0.7619 Intermediate Similarity NPD3750 Approved
0.7614 Intermediate Similarity NPD8151 Discontinued
0.76 Intermediate Similarity NPD7819 Suspended
0.7598 Intermediate Similarity NPD3787 Discontinued
0.7588 Intermediate Similarity NPD1511 Approved
0.7584 Intermediate Similarity NPD5494 Approved
0.7579 Intermediate Similarity NPD6535 Approved
0.7579 Intermediate Similarity NPD6534 Approved
0.7565 Intermediate Similarity NPD6782 Approved
0.7565 Intermediate Similarity NPD6776 Approved
0.7565 Intermediate Similarity NPD6778 Approved
0.7565 Intermediate Similarity NPD6777 Approved
0.7565 Intermediate Similarity NPD6781 Approved
0.7565 Intermediate Similarity NPD6780 Approved
0.7565 Intermediate Similarity NPD6779 Approved
0.7553 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD5401 Approved
0.754 Intermediate Similarity NPD8150 Discontinued
0.7487 Intermediate Similarity NPD7874 Approved
0.7487 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6799 Approved
0.7461 Intermediate Similarity NPD7700 Phase 2
0.7461 Intermediate Similarity NPD7699 Phase 2
0.7429 Intermediate Similarity NPD6599 Discontinued
0.7425 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD943 Approved
0.7384 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD3749 Approved
0.736 Intermediate Similarity NPD7697 Approved
0.736 Intermediate Similarity NPD7696 Phase 3
0.736 Intermediate Similarity NPD7698 Approved
0.7354 Intermediate Similarity NPD8434 Phase 2
0.7341 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7870 Phase 2
0.7323 Intermediate Similarity NPD7871 Phase 2
0.7321 Intermediate Similarity NPD1510 Phase 2
0.7321 Intermediate Similarity NPD3748 Approved
0.731 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD8455 Phase 2
0.73 Intermediate Similarity NPD7701 Phase 2
0.7294 Intermediate Similarity NPD1549 Phase 2
0.7288 Intermediate Similarity NPD7411 Suspended
0.7277 Intermediate Similarity NPD7801 Approved
0.7273 Intermediate Similarity NPD7680 Approved
0.7263 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD6959 Discontinued
0.7241 Intermediate Similarity NPD2532 Approved
0.7241 Intermediate Similarity NPD2533 Approved
0.7241 Intermediate Similarity NPD2534 Approved
0.7238 Intermediate Similarity NPD919 Approved
0.7235 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD4628 Phase 3
0.7186 Intermediate Similarity NPD1613 Approved
0.7186 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD7458 Discontinued
0.7174 Intermediate Similarity NPD3926 Phase 2
0.7169 Intermediate Similarity NPD3764 Approved
0.7165 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD6212 Phase 3
0.7165 Intermediate Similarity NPD6213 Phase 3
0.7143 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD9269 Phase 2
0.7079 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD2796 Approved
0.7068 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD1247 Approved
0.7062 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7799 Discontinued
0.705 Intermediate Similarity NPD6823 Phase 2
0.7045 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD7783 Phase 2
0.7024 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD8166 Discontinued
0.7006 Intermediate Similarity NPD3027 Phase 3
0.7005 Intermediate Similarity NPD7930 Approved
0.6983 Remote Similarity NPD3226 Approved
0.6982 Remote Similarity NPD1240 Approved
0.6973 Remote Similarity NPD8127 Discontinued
0.697 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7585 Approved
0.6954 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6949 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6946 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6941 Remote Similarity NPD6355 Discontinued
0.694 Remote Similarity NPD7768 Phase 2
0.6912 Remote Similarity NPD7583 Approved
0.6912 Remote Similarity NPD7584 Approved
0.6911 Remote Similarity NPD8368 Discontinued
0.691 Remote Similarity NPD6273 Approved
0.6901 Remote Similarity NPD1607 Approved
0.6898 Remote Similarity NPD5242 Approved
0.6893 Remote Similarity NPD7390 Discontinued
0.6891 Remote Similarity NPD8407 Phase 2
0.6886 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6885 Remote Similarity NPD5353 Approved
0.6882 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6882 Remote Similarity NPD4060 Phase 1
0.6879 Remote Similarity NPD2935 Discontinued
0.6864 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6857 Remote Similarity NPD6674 Discontinued
0.6852 Remote Similarity NPD9268 Approved
0.6845 Remote Similarity NPD5710 Approved
0.6845 Remote Similarity NPD5711 Approved
0.6845 Remote Similarity NPD7229 Phase 3
0.6842 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6836 Remote Similarity NPD7236 Approved
0.6818 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6798 Remote Similarity NPD5006 Approved
0.6798 Remote Similarity NPD5005 Approved
0.6793 Remote Similarity NPD4288 Approved
0.6782 Remote Similarity NPD5406 Approved
0.6782 Remote Similarity NPD1551 Phase 2
0.6782 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6782 Remote Similarity NPD5408 Approved
0.6782 Remote Similarity NPD5405 Approved
0.6782 Remote Similarity NPD5404 Approved
0.6782 Remote Similarity NPD6099 Approved
0.6782 Remote Similarity NPD6100 Approved
0.6778 Remote Similarity NPD920 Approved
0.6771 Remote Similarity NPD5953 Discontinued
0.6765 Remote Similarity NPD6798 Discontinued
0.6763 Remote Similarity NPD4978 Clinical (unspecified phase)
0.676 Remote Similarity NPD642 Clinical (unspecified phase)
0.6744 Remote Similarity NPD1933 Approved
0.6743 Remote Similarity NPD2346 Discontinued
0.6743 Remote Similarity NPD5762 Approved
0.6743 Remote Similarity NPD5763 Approved
0.674 Remote Similarity NPD7239 Suspended
0.6703 Remote Similarity NPD3455 Phase 2
0.6699 Remote Similarity NPD7999 Approved
0.6687 Remote Similarity NPD9545 Approved
0.6686 Remote Similarity NPD9494 Approved
0.6684 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6683 Remote Similarity NPD4004 Approved
0.6683 Remote Similarity NPD4420 Approved
0.6683 Remote Similarity NPD4002 Approved
0.6667 Remote Similarity NPD8361 Approved
0.6667 Remote Similarity NPD3452 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data